Rating Change
Barclays reiterated its Equal-Weight rating on Insulet Corporation (NASDAQ:PODD) on November 06, 2026.
reiterateNASDAQ:PODD
Barclays Reiterates Equal-Weight Rating on Insulet Corporation (PODD)
Barclays reiterated its Equal-Weight rating on Insulet Corporation (NASDAQ:PODD) on November 06, 2026.
At publication ·
What changed
Insulet Corporation (NASDAQ:PODD) · reiterate
- Firm
- Barclays
- Rating
- Equal-Weight to Equal-Weight
- Price at event
- $146.51
- Market capitalization
- $20.7B
At a glance
Key takeaways
- Barclays maintained an Equal-Weight rating on Insulet Corporation (PODD) on November 6, 2026, indicating neutral sentiment on the stock.
Market Context
Insulet Corporation operates in the Healthcare sector. The stock currently trades at $146.51 with a market capitalization of $20.7B. The stock has declined 46.7% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Insulet Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Insulet Corporation
Among the 10 most recent ratings: 3 Buy, 7 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 06, 2026 | Barclays | Equal-Weight | N/A |
| Nov 05, 2026 | Citigroup | Neutral | N/A |
| Nov 05, 2026 | JP Morgan | Neutral | N/A |
| Nov 05, 2026 | UBS | Neutral | N/A |
| Nov 05, 2026 | Leerink Partners | Market Perform | N/A |
Related Tools: Analyst Ratings Dashboard | View PODD Stock Page
Frequently Asked Questions
What does the Equal-Weight rating mean for PODD?
A rating of Equal-Weight from Barclays reflects the analyst's outlook on Insulet Corporation (NASDAQ:PODD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PODD forecast page.
